from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2849c/cobO

LFCtreatmentdescriptionclass of inhibitor

-0.797

Amikacinug/mL Amikacintranslation

-3.371

Cap5-10ug/mL Capreomycintranslation

-2.554

Rox10-50 ug/mL Roxithromycintranslation

-0.542

SM2-5 ug/mL Streptomycintranslation

-1.032

Tet5-10 ug/mL Tetracyclinetranslation

0.674

Rif0.2-5ug/mL Rifampicintranscription

-0.975

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.720

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.151

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.199

CPZ10-50 ug/mL Chlorpromazinerespiration

1.413

Clofazimine10-13 ug/mL Clofaziminerespiration

0.132

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.686

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.019

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.130

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.116

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.996

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.216

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.190

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.409

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.132

KCN5-20 ug/mL Potassium cyaniderespiration

0.108

NaN30.2-2 mM Sodium aziderespiration

-0.596

Nigericin50 uM Nigericinrespiration

0.441

TRC10-150 ug/mL Triclosanrespiration

1.248

TRZ10-25 ug/mL Thioridazinerespiration

-1.932

Valinomycin0.5-10 uM Valinomycinrespiration

-1.274

ZnSO42 mM ZnSO4respiration

-0.261

menadione6-10 ug/mL Menadionerespiration

0.989

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.114

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.031

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.396

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.849

NRP_1Non-replicating persistence stage 1dosRassociated

0.147

Amp0.2mg/mL AmpicillincellWall

0.478

Cephalexin20-100 ug/mL CephalexincellWall

-0.455

Cerulenin0.32-5 ug/mL CerulenincellWall

1.175

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.702

EMB10-20 ug/mL EthambutolcellWall

-0.118

Eta12-40 ug/mL EthionamidecellWall

0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

0.314

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.452

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.931

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.217

BZA0.12 mg/mL BenzamidearomaticAmides

-0.079

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.022

H2O24 mM hydrogen peroxideDNAdamaging

-1.997

Levo10 ug/mL LevofloxacinDNAdamaging

-0.232

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.494

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.001

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.136

UVUV-irradiationDNAdamaging

0.705

ARP41-4 ug/mL Antitubercular compound ARP4?

0.226

Antimycin12.5-50 ug/mL Antimycin A?

-0.659

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.198

PA_110-50 ug/mL Antitubercular compound PA-1?

0.617

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.762

PA8240.2-2 ug/mL PA-824?

0.353

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.176

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.411

Verapamil50 uM Verapamil?

-0.345

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.080

methoxatin10-20 ug/mL Methoxatin?